| Literature DB >> 28461533 |
Niti Goel1,2, Denis O'Sullivan3,4, Ingrid Steinkoenig3,4, Jana James3,4, Chris A Lindsay3,4, Laura C Coates3,4, John Latella3,4, Alexis Ogdie3,4, Jeffrey Chau3,4, Heidi Bertheussen3,4, Willemina Campbell3,4.
Abstract
In line with the global trend to have disease-related organizations be more patient-centric in their approach, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has made substantial progress incorporating patient research partners (PRP) into psoriatic arthritis and psoriasis research. Herein we summarize the involvement of PRP at the GRAPPA 2016 annual meeting. Plans for future PRP engagement were also discussed.Entities:
Keywords: GRAPPA; PATIENT CENTRICITY; PATIENT RESEARCH PARTNERS; PSORIASIS; PSORIATIC ARTHRITIS
Mesh：
Year: 2017 PMID： 28461533 DOI： 10.3899/jrheum.170152
Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666